Stryker acquires OrthoSpace for biodegradable balloon technology for $220M

[et_pb_section fb_built="1" admin_label="section" _builder_version="3.0.47"][et_pb_row admin_label="row" _builder_version="3.0.48" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4" _builder_version="3.0.47" parallax="off" parallax_method="on"][et_pb_text admin_label="Text" _builder_version="3.0.74" background_size="initial" background_position="top_left" background_repeat="repeat"]  

 

 

Well, Stryker just acquired one of my 12 Hot Startups on the list - OrthoSpace.  I love these guys. A unique simple solution to a clinical problem of cuff tears rubbing against bones in the elderly without a big surgery.  OrthoSpace had literally NO COMPETITION in the new treatment category that they created.   Read this to understand what OrthoSpace's technology does -  OrthoSpace’s resorbable InSpace Balloon reduces rotator cuff pain for patients

  --------------------------------------------------------------

Stryker pays up to $220m for OrthoSpace (MassDevice) Stryker (NYSE:SYK) said today that it put $220 million on the table for OrthoSpace and its InSpace rotator cuff repair device. Stryker said it paid $110...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top